1) Polylactic acid temozolomide
聚乳酸-替莫唑胺
2) temozolomide polylactic-co-glycolic acid microspheres
替莫唑胺聚乳酸-羟基醋酸微球
1.
Study on preparation of temozolomide polylactic-co-glycolic acid microspheres and drug release in vitro;
替莫唑胺聚乳酸-羟基醋酸微球的制备及体外释药
3) temozolomide
替莫唑胺
1.
Effects of temozolomide capsules in treatment of 31 Chinese patients with malignant gliomas;
替莫唑胺治疗国人恶性脑胶质瘤:31例临床疗效分析
2.
Evaluation of the Efficacy of Radiotherapy Concurrent Temozolomide Chemotherapyin Patients with Brain Metastases;
放疗同步口服替莫唑胺治疗颅内转移瘤疗效评价
3.
Clinical Observation in Temozolomide Combined with Radiotherapy in Treatment of Postoperative Malignant Glioma;
恶性胶质瘤术后应用替莫唑胺化疗联合放疗的临床观察
4) Temozolomide (TMZ)
替莫唑胺(TMZ)
5) temozolomide hexyl ester
替莫唑胺酯
1.
Objective: To develop a method so as to determine the related substances in the temozolomide hexyl ester.
目的:建立替莫唑胺酯中有关物质的测定方法。
6) temozolomide analogues
替莫唑胺类似物
1.
On the base of the characteristics and the physiochemical properties of novel antitumor drug temozolomide, seventeen temozolomide analogues were designed and synthesized, including eight 3-methyl-4-oxoimidazo[5,l-d][l,2,3,5]tetrazine-8-carboxylates (Ia-Ih) and nine 3-methyl-4-oxoimidazo[5,1-d.
针对抗癌新药替莫唑胺的作用特点和理化性质，以替莫唑胺及其活性代谢物3-甲基-4-氧代咪唑[5，1-d][1，2，3，5]四嗪-8-羧酸(Ⅲ)为先导化合物，设计合成了17个替莫唑胺类似物，其中8个3-甲基-4-氧代咪唑[5，1-d][1，2，3，5]四嗪-8-羧酸酯类化合物(Ia～Ih)，9个3-甲基-4-氧代咪唑[5，1-d][1，2，3，5]四嗪-8-酰胺类化合物(Ⅱa～Ⅱi)，均为未见文献报道的新化合物。
补充资料：替莫唑胺
分子式：C6H6N6O2
分子量：暂无
CAS号：85622-93-1
性质：暂无
制备方法：暂无
用途：抗肿瘤药
分子量：暂无
CAS号：85622-93-1
性质：暂无
制备方法：暂无
用途：抗肿瘤药
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条